Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ERINHA-Advance

Financiado

Cerrado

Advancing European Research Infrastcuture on Highly Pathogenic Agents

One of the great challenges of the 21st century is to develop the capacity to prevent and react to outbreaks caused by highly pathogenic human and animal microorganisms, which are generally characterized by a high mortality rate,... ver más

30/06/2022

ERINHA

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PA... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 12 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-06-30

INFRADEV-03-2018-2019: Individual support to ESFRI and oth... Specific Challenge:The implementation phase of new pan-European research infrastructures, such as th...

I+D

Cerrada hace 7 años

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

12 Participantes

ERINHA

1.76M€ | Lider

BNI

43.75K€ | Participante

KU Leuven

104.37K€ | Participante

FOHM

342.50K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 43 meses Fecha Inicio: 2018-11-20
Fecha Fin: 2022-06-30

Líder del proyecto

EUROPEAN RESEARCH INFRASTRUCTURE ON HIGHLY PA... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto One of the great challenges of the 21st century is to develop the capacity to prevent and react to outbreaks caused by highly pathogenic human and animal microorganisms, which are generally characterized by a high mortality rate, unavailability of prophylactics or effective therapeutic treatment and high human-to-human transmission. ERINHA AISBL (European Research Infrastructure on Highly Pathogenic Agents), a pan-European Research Infrastructure (RI) dedicated to the study of high-consequence pathogens of Risk Group 4 (RG4), entered into implementation phase in July 2017. It now aims to ensure its long-term sustainability to better answer societal challenges in the field of Science, Health and Security. The overall aim of the ERINHA-Advance project is to implement actions that will contribute to the long-term sustainability of the ERINHA RI, through enlargement of its membership and partnership and strengthening the overall services offer and framework by fostering the innovation potential of the RI. To reach these goals, the RI will focus on the following specific objectives: 1. Enlarge ERINHA’s membership and research capacities (WP2); 2. Improve users services (WP3); 3. Stimulate the innovation potential of ERINHA and identify the co-innovation opportunities with industry (WP4); 4. Strengthen the overall services framework through long-term data-management and data sharing rules, clarification of IPR regimes and definition and implementation of the quality assurance system of the RI and its national nodes (WP5); 5. Reinforce ERINHA’s European and International cooperation with relevant countries, initiatives and networks (WP2 and WP6). By achieving these objectives, ERINHA-Advance will largely contribute to providing access to larger number of high containment facilities to European and international scientists and foster research and innovation in the field of highly infectious diseases.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores